SCHEMBL30313610

SCHEMBL30313610

CCCCOC(=O)c1ccnc2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.60
L3MBTL1 Q9Y468 3/20 0.60
TDP1 Q9NUW8 2/20 0.60
CYP3A4 P08684 4/20 0.55
MAPK1 P28482 3/20 0.55
TP53 P04637 1/20 0.55
KDM4E B2RXH2 5/20 0.54
KDM4A O75164 1/20 0.54
KDM4C Q9H3R0 1/20 0.54
ALDH1A1 P00352 9/20 0.54
LMNA P02545 3/20 0.54
HSD17B10 Q99714 2/20 0.54
HPGD P15428 2/20 0.49
RXFP1 Q9HBX9 1/20 0.49
PLA2G2A P14555 1/20 0.48
POLB P06746 1/20 0.48
CYP1A2 P05177 1/20 0.47
MAPT P10636 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13610182 0.95 ALDH1A1 (0.62) TSHRL3MBTL1TDP1CYP3A4MAPK1
SCHEMBL1768671 0.85 NUDT1 (0.57) TSHRL3MBTL1CYP3A4TP53KDM4E
SCHEMBL29523397 0.85 NUDT1 (0.57) TSHRL3MBTL1CYP3A4TP53KDM4E
SCHEMBL16859557 0.82 TSHR (0.77) TSHRL3MBTL1TDP1CYP3A4MAPK1
SCHEMBL29671333 0.82 TSHR (0.77) TSHRL3MBTL1TDP1CYP3A4MAPK1
SCHEMBL30604067 0.82 ATM (0.69) TSHRL3MBTL1TDP1CYP3A4MAPK1
SCHEMBL29259654 0.81 ALDH1A1 (0.51) TDP1CYP3A4KDM4EALDH1A1LMNA
SCHEMBL9200082 0.80 HTR3E (0.62) TSHRL3MBTL1TDP1CYP3A4MAPK1
SCHEMBL30201809 0.80 LMNA (0.50) CYP3A4TP53KDM4EALDH1A1LMNA
SCHEMBL31310820 0.80 PLA2G2A (0.65) TSHRL3MBTL1TDP1CYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115867284-A Heterocyclic compounds as trigger receptor 2 agonists expressed on myeloid cells and methods of use 安进公司 2023-03-28 CN disclosed